Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Patient perspective: choosing or developing instruments.

Kirwan JR, Fries JF, Hewlett S, Osborne RH.

J Rheumatol. 2011 Aug;38(8):1716-9. doi: 10.3899/jrheum.110390.

PMID:
21807791
2.

Overview of the patient perspective at OMERACT 10--conceptualizing methods for developing patient-reported outcomes.

Kirwan JR, Tugwell PS.

J Rheumatol. 2011 Aug;38(8):1699-701. doi: 10.3899/jrheum.110388.

PMID:
21807788
3.

Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis.

Kirwan JR, Minnock P, Adebajo A, Bresnihan B, Choy E, de Wit M, Hazes M, Richards P, Saag K, Suarez-Almazor M, Wells G, Hewlett S.

J Rheumatol. 2007 May;34(5):1174-7.

PMID:
17477482
4.

Patient perspective: reasons and methods for measuring fatigue in rheumatoid arthritis.

Kirwan JR, Hewlett S.

J Rheumatol. 2007 May;34(5):1171-3.

PMID:
17477481
5.

OMERACT 10 Patient Perspective Virtual Campus: valuing health; measuring outcomes in rheumatoid arthritis fatigue, RA sleep, arthroplasty, and systemic sclerosis; and clinical significance of changes in health.

Kirwan JR, Boonen A, Harrison MJ, Hewlett SE, Wells GA, Singh JA, Furst DE, Dworkin RH.

J Rheumatol. 2011 Aug;38(8):1728-34. doi: 10.3899/jrheum.110393.

PMID:
21807793
6.

Progress since OMERACT 6 on including patient perspective in rheumatoid arthritis outcome assessment.

Kirwan JR, Ahlmén M, de Wit M, Heiberg T, Hehir M, Hewlett S, Katz PP, Minnock P, Quest EM, Richards P.

J Rheumatol. 2005 Nov;32(11):2246-9.

PMID:
16265711
7.

Patient perspective workshop: moving towards OMERACT guidelines for choosing or developing instruments to measure patient-reported outcomes.

Kirwan JR, Fries JF, Hewlett SE, Osborne RH, Newman S, Ciciriello S, van de Laar MA, Dures E, Minnock P, Heiberg T, Sanderson TC, Flurey CA, Leong AL, Montie P, Richards P.

J Rheumatol. 2011 Aug;38(8):1711-5. doi: 10.3899/jrheum.110391.

PMID:
21807790
8.

Domains selection for patient-reported outcomes: current activities and options for future methods.

Tugwell PS, Petersson IF, Boers M, Gossec L, Kirwan JR, Rader T, Sanderson TC, van de Laar MA, Ueffing E, Witter JP.

J Rheumatol. 2011 Aug;38(8):1702-10. doi: 10.3899/jrheum.110389.

PMID:
21807789
9.

Incorporating the patient perspective into outcome assessment in rheumatoid arthritis--progress at OMERACT 7.

Kirwan JR, Hewlett SE, Heiberg T, Hughes RA, Carr M, Hehir M, Kvien TK, Minnock P, Newman SP, Quest EM, Taal E, Wale J.

J Rheumatol. 2005 Nov;32(11):2250-6.

PMID:
16265712
10.

It's good to feel better but it's better to feel good and even better to feel good as soon as possible for as long as possible. Response criteria and the importance of change at OMERACT 10.

Strand V, Boers M, Idzerda L, Kirwan JR, Kvien TK, Tugwell PS, Dougados M.

J Rheumatol. 2011 Aug;38(8):1720-7. doi: 10.3899/jrheum.110392.

PMID:
21807792
11.

Patient perspective on remission in rheumatoid arthritis.

van Tuyl LH, Smolen JS, Wells GA, Scholte-Voshaar M, Hoogland W, Boers M.

J Rheumatol. 2011 Aug;38(8):1735-8. doi: 10.3899/jrheum.110394.

PMID:
21807794
12.

Patient perspective in outcome assessments--perceptions or something more?

Kvien TK, Heiberg T.

J Rheumatol. 2003 Apr;30(4):873-6. Review.

PMID:
12672219
13.

Valuing health for clinical and economic decisions: directions relevant for rheumatologists.

Harrison MJ, Bansback NJ, Marra CA, Drummond M, Tugwell PS, Boonen A.

J Rheumatol. 2011 Aug;38(8):1770-5. doi: 10.3899/jrheum.110404.

PMID:
21807800
14.

Outcomes from the Patient Perspective Workshop at OMERACT 6.

Kirwan J, Heiberg T, Hewlett S, Hughes R, Kvien T, Ahlmèn M, Boers M, Minnock P, Saag K, Shea B, Suarez Almazor M, Taal E.

J Rheumatol. 2003 Apr;30(4):868-72. Review.

PMID:
12672218
15.

Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop.

Bingham CO 3rd, Alten R, Bartlett SJ, Bykerk VP, Brooks PM, Choy E, Christensen R, Furst DE, Hewlett SE, Leong A, May JE, Montie P, Pohl C, Sanderson TC, Strand V, Woodworth TG; OMERACT RA Flare Definition Working Group.

J Rheumatol. 2011 Aug;38(8):1751-8. doi: 10.3899/jrheum.110401.

PMID:
21807797
16.

Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues.

Tubach F, Wells GA, Ravaud P, Dougados M.

J Rheumatol. 2005 Oct;32(10):2025-9. Review.

PMID:
16206363
17.

Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group.

Alten R, Pohl C, Choy EH, Christensen R, Furst DE, Hewlett SE, Leong A, May JE, Sanderson TC, Strand V, Woodworth TG, Bingham CO 3rd; OMERACT RA Flare Definition Working Group.

J Rheumatol. 2011 Aug;38(8):1745-50. doi: 10.3899/jrheum.110400.

PMID:
21807796
18.

Incorporating the patient's perspective in outcomes research.

Hsiao B, Fraenkel L.

Curr Opin Rheumatol. 2017 Mar;29(2):144-149. doi: 10.1097/BOR.0000000000000372. Review.

PMID:
28072590
19.

Development and validation of a preference weight multiattribute health outcome measure for rheumatoid arthritis.

Chiou CF, Suarez-Almazor ME, Sherbourne CD, Chang CH, Reyes C, Dylan M, Ofman J, Wallace DJ, Mizutani W, Weisman M.

J Rheumatol. 2006 Dec;33(12):2409-11. Epub 2006 Oct 15.

PMID:
17080516
20.

[Rheumatoid arthritis. Target outcome for treatment].

Aletaha D, Smolen J.

Z Rheumatol. 2009 Feb;68(1):10-5. doi: 10.1007/s00393-008-0357-7. Review. German.

PMID:
19148656

Supplemental Content

Support Center